Shuyan Zeng
Overview
Explore the profile of Shuyan Zeng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng S, Zhang J, Jiang W, Zeng C
Mol Biol Rep
. 2025 Feb;
52(1):188.
PMID: 39899168
Background: SERPINB5, also known as Maspin, is a non-inhibitory member of the serine protease inhibitor superfamily. SERPINB5 exerts diverse effects on a variety of human cancers, including cell proliferation, angiogenesis,...
2.
Fu Y, Zeng S, Wang Z, Huang H, Zhao X, Li M
Pharmaceuticals (Basel)
. 2025 Jan;
18(1).
PMID: 39861161
As a structural and catalytic cofactor, copper is involved in many biological pathways and is required for the biochemistry of all living organisms. However, excess intracellular copper can induce cell...
3.
Zeng S, Kong Q, Wu X, Duan M, Nan X, Yang X, et al.
Int J Antimicrob Agents
. 2024 Sep;
64(5):107325.
PMID: 39245326
Background: Empirical treatment needs to be supported by regional data, but knowledge of interregional differences is currently lacking in China. This study aimed to summarize and map the primary and...
4.
Zeng S, Kong Q, Wu X, Ma T, Wang L, Xu L, et al.
Helicobacter
. 2024 Aug;
29(4):e13115.
PMID: 39097925
Background: Patient education contributes to improve public awareness of Helicobacter pylori. Large language models (LLMs) offer opportunities to revolutionize patient education transformatively. This study aimed to assess the quality of...
5.
Han Z, Zhang Q, Mirza I, Ding Y, Nan X, Zhao Q, et al.
Helicobacter
. 2024 Jun;
29(3):e13102.
PMID: 38873902
Background: The optimal dosage of tetracycline remains unclear for Helicobacter pylori eradication. Frequent dosing requirements may decrease patient adherence and increase the incidence of adverse events, potentially reducing treatment efficacy....
6.
Wu X, Duan M, Kong Q, Zeng S, Xu L, Li Y, et al.
Helicobacter
. 2024 May;
29(1):e13048.
PMID: 38716864
Current global variations exist in Helicobacter pylori (H. pylori) eradication regimens. Triple therapy (TT), bismuth quadruple therapy (BQT), and high-dose dual therapy (HDDT) currently represent the predominant regimens. These regimens...
7.
Jing W, Wang G, Cui Z, Li X, Zeng S, Jiang X, et al.
Proc Natl Acad Sci U S A
. 2024 May;
121(20):e2312855121.
PMID: 38713626
The immune landscape of bladder cancer progression is not fully understood, and effective therapies are lacking in advanced bladder cancer. Here, we visualized that bladder cancer cells recruited neutrophils by...
8.
Liu B, Xie Y, Zhang J, Zeng S, Li J, Tao Q, et al.
Int Immunopharmacol
. 2024 Mar;
131:111759.
PMID: 38460302
This study aimed to investigate the role of SERPINB5 in colorectal cancer (CRC). We established knockdown and overexpression models of SERPINB5 in CRC cells and conducted bioinformatics analysis to assess...
9.
Zeng S, Tian Z, Gong F, Wang F, Xie M, Chen X, et al.
Int Wound J
. 2024 Feb;
21(2):e14662.
PMID: 38402555
To compare fluidized positioners and gel pads for skin protection in neurosurgery patients placed in lateral and prone positions. It is one of the major challenges that operating room nurses...
10.
Cao L, Dayimu A, Guan X, Duan M, Zeng S, Wang H, et al.
Inflamm Res
. 2024 Jan;
73(2):277-287.
PMID: 38184814
Aims: Inflammatory bowel disease (IBD) is a global disease. We aim to summarize the latest epidemiological patterns of IBD at the national, regional and global levels to give well-deserved attention...